India is expected to see a GLP-1 boom as Novo Nordisk’s semaglutide patent expires in the country this month. GLP-1s such as Wegovy and Ozempic have made a big impact in the treatment of diabetes and weight loss, especially in the US. The expiring patent marks an important moment for India’s pharmaceutical and nutritional sectors, … Read more
(Photo Credit: Artem Krupetskiy / Shutterstock) SlimQuick class action lawsuit overview: WHO: Consumers filed a class action lawsuit against Platinum US Distribution Inc., WellNX Life Sciences Inc. and WellNX Life Sciences DR Inc. Why: The plaintiffs allege the company falsely advertise their SlimQuick weight loss supplements as safe and effective. where: The SlimQuick class action … Read more
Ingredion has partnered with Holobiome to use AI and a database of two million bacterial genomes to predict how specific ingredients will interact with human health before clinical trials. Research extends beyond digestion to explore how sweeteners, plant proteins, and texture solutions affect the gut-brain axis, including sleep and mental health. This data-driven insight allows … Read more
A new tool that not only identifies diet and nutrition misinformation online but also assesses the risk of content for potential harm has been developed by a UCL research team. Unlike existing tools, which offer a binary assessment of whether the content is ‘true’ or ‘false’, this first-of-its-kind tool addresses misinformation that is not blatantly … Read more